Literature DB >> 10893221

RhoA and rho kinase regulate the epithelial Na+/H+ exchanger NHE3. Role of myosin light chain phosphorylation.

K Szászi1, K Kurashima, A Kapus, A Paulsen, K Kaibuchi, S Grinstein, J Orlowski.   

Abstract

The activity of the Na(+)/H(+) exchanger NHE3 isoform, which is found primarily in epithelial cells, is sensitive to the state of actin polymerization. Actin assembly, in turn, is controlled by members of the small GTPase Rho family, namely Rac1, Cdc42, and RhoA. We therefore investigated the possible role of these GTPases in modulating NHE3 activity. Cells stably expressing NHE3 were transiently transfected with inhibitory forms of Rac1, Cdc42, or RhoA and transport activity was assessed using microfluorimetry. NHE3 activity was not adversely affected by either dominant-negative Rac1 or Cdc42. By contrast, the inhibitory form of RhoA greatly depressed NHE3 activity, without noticeably altering its subcellular distribution. NHE3 activity was equally reduced by inhibiting p160 Rho-associated kinase I (ROK), a downstream effector of RhoA, with the selective antagonist Y-27632 and a dominant-negative form of ROK. Furthermore, inhibition of ROK reduced the phosphorylation of myosin light chain. A comparable net dephosphorylation was achieved by the myosin light chain kinase inhibitor ML9, which similarly inhibited NHE3. These data suggest that optimal NHE3 activity requires a functional RhoA-ROK signaling pathway which acts, at least partly, by controlling the phosphorylation of myosin light chain and, ultimately, the organization of the actin cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10893221     DOI: 10.1074/jbc.M001193200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Towards a physiology of epithelial pathogens.

Authors:  I Cook; A Young
Journal:  Pflugers Arch       Date:  2001-11-01       Impact factor: 3.657

2.  Akt2 phosphorylates ezrin to trigger NHE3 translocation and activation.

Authors:  Harn Shiue; Mark W Musch; Yingmin Wang; Eugene B Chang; Jerrold R Turner
Journal:  J Biol Chem       Date:  2004-11-04       Impact factor: 5.157

3.  The calcineurin homologous protein-1 increases Na(+)/H(+) -exchanger 3 trafficking via ezrin phosphorylation.

Authors:  Francesca Di Sole; Victor Babich; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2009-06-25       Impact factor: 10.121

4.  Lysophosphatidic acid stimulation of NHE3 exocytosis in polarized epithelial cells occurs with release from NHERF2 via ERK-PLC-PKCδ signaling.

Authors:  Boyoung Cha; Tiane Chen; Rafiquel Sarker; Jianbo Yang; Daniel Raben; C Ming Tse; Olga Kovbasnjuk; Mark Donowitz
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-23       Impact factor: 4.249

Review 5.  Involvement of Rho GTPases and their regulators in the pathogenesis of hypertension.

Authors:  Gervaise Loirand; Pierre Pacaud
Journal:  Small GTPases       Date:  2014-10-31

6.  The GTP-binding protein RhoA mediates Na,K-ATPase exocytosis in alveolar epithelial cells.

Authors:  Emilia Lecuona; Karen Ridge; Liuska Pesce; Daniel Batlle; Jacob I Sznajder
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

Review 7.  Diversity of the mammalian sodium/proton exchanger SLC9 gene family.

Authors:  John Orlowski; Sergio Grinstein
Journal:  Pflugers Arch       Date:  2003-07-04       Impact factor: 3.657

8.  CCK activates RhoA and Rac1 differentially through Galpha13 and Galphaq in mouse pancreatic acini.

Authors:  Maria E Sabbatini; Yan Bi; Baoan Ji; Stephen A Ernst; John A Williams
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-25       Impact factor: 4.249

9.  Dysfunctional cystic fibrosis transmembrane conductance regulator inhibits phagocytosis of apoptotic cells with proinflammatory consequences.

Authors:  R William Vandivier; Tiffany R Richens; Sarah A Horstmann; Aimee M deCathelineau; Moumita Ghosh; Susan D Reynolds; Yi-Qun Xiao; David W Riches; Jonathan Plumb; Eric Vachon; Gregory P Downey; Peter M Henson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-24       Impact factor: 5.464

Review 10.  Druggable targets in the Rho pathway and their promise for therapeutic control of blood pressure.

Authors:  Rachel A Dee; Kevin D Mangum; Xue Bai; Christopher P Mack; Joan M Taylor
Journal:  Pharmacol Ther       Date:  2018-09-04       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.